학술논문
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
Document Type
Article
Author
Source
In Annals of Oncology June 2017 28(6):1339-1345
Subject
Language
ISSN
0923-7534